27 November 2020
Asthmatics, diabetics and former cancer patients may have contraindications from a coronavirus vaccine, Head of the Department of General Virology of the Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences Georgy Ignatyev said at a press conference at TASS.
“Today, in the clinical trials protocol people with these diagnoses are listed as non-admission criteria, they cannot volunteer. According to the accepted practice in our country, the protocol criteria is then transferred to the vaccine manual. <…> In all likelihood, taking into account the first use of these vaccines, I don’t think that they’ll opt to use these vaccines on people with such diagnoses,” he said in response to a question whether people with diabetes and asthma have contraindications to the vaccination.
Additionally, according to the scientist, a history of cancer will also be a contraindication to the inoculation.
The Center has developed its own whole-virion inactivated vaccine against the coronavirus. The preparation has already successfully passed pre-clinical trials and is currently undergoing clinical trials. Either artificially weakened viruses incapable of causing a disease or dead (inactivated) viruses are used in the whole-virion vaccines. Large-scale production of the vaccine against the coronavirus developed by the Chumakov Center may begin in February 2021.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Putin has stated that Russia will support Africa in the struggle against epidemics
19 April 2024
The Russian government has expanded the list of vital and essential drugs
19 April 2024
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024